Shopping Cart
×

Joyance Partners

Joyance Partners

  • San Francisco, California, United States

  • San Francisco, California

Stage

  • Early Stage

Type

  • Venture Capital

Description

Joyance invests in companies that, through science and tech, cultivate joy to improve the way we live across North America, Europe, and Asia. We focus on the health and consumer sectors from pre-seed to Series A.

Mission

Health, Happiness, Longevity:

Joyance Partners’ mission is to invest in startups that are developing innovative solutions to enhance health, happiness, and longevity for individuals and communities.

Beauty Investments #

  • 4

Primary Sector

  • Health care and Biotechnoloy

Beauty Exits #

  • 0

Last Beauty Invest

  • Dec, 2021-Bloom Science-$12M

BEAUTY PORTFOLIO

How to Apply?

Application Form on Site: https://www.joyancepartners.com/contact

Criteria

Innovative Solutions:
Startups with innovative products, services, or technologies that address significant challenges or opportunities within the health, happiness, and longevity sectors. Emphasis on disruptive ideas and approaches that have the potential to transform industries and improve outcomes.
Market Potential:
Large and growing markets with opportunities for significant impact and scalability. Startups targeting underserved or overlooked segments within healthcare, wellness, mental health, aging, and related fields.
Founder and Team:
Strong and visionary founders with deep domain expertise, passion, and commitment to their mission. Emphasis on diverse teams and leadership that bring unique perspectives and insights to the table.
Traction and Validation:
Evidence of market traction, customer validation, and early adoption of the product or service. Demonstrated progress in product development, user acquisition, revenue generation, or partnerships.
Scalability and Growth Potential:
Scalable business models with the potential for rapid growth and expansion. Clear pathways to achieving scalability through technology, network effects, or other strategic advantages.
Impact and Mission Alignment:
Alignment with Joyance Partners’ mission to improve health, happiness, and longevity through innovation. Startups that have a positive impact on individuals, communities, and society as a whole.
Defensibility and Competitive Advantage:
Strong intellectual property, proprietary technology, or unique value proposition that provides a competitive advantage. Barriers to entry and defensibility against potential competitors.
Fit with Portfolio:
Alignment with Joyance Partners’ investment thesis, focus areas, and portfolio strategy. Potential for synergies and collaboration with existing portfolio companies.

Resources Breakdown Funding Terms
  • $100,000 to $1 million

  • Preferred Stock, Convertible Notes

Education
  • No
Accelerator
  • Type-No
  • Duration-No
Network
  • 80+ Startups/Decent Network
1:1
  • Yes

IMPERATIVE: CULTURE & VALUES

TBD

TBD

TBD

TBD

Impactful Innovation

TBD

BEAUTY FUNDER FIT SCORE

Resources

Education

Accelerator

Network

1:1

5.55/10

Inclusivity Investments %
  • 35.00%
Beauty Investments #
  • 4

Beauty Exits #
  • 0
Last Beauty Invest
  • Dec, 2021-Bloom Science-$12M

LEAD DETAILS

Lead Contact

Thibault Vanvincq

Title

Investment Partner

Twitter Handle

Joyance Partners

JUMP CONCLUSION

Joyance Partners focuses on early-stage companies using science and tech for health enhancement, with a strong presence in California and international investments in Europe and Canada. Their portfolio emphasizes Health Care, Biotechnology, and Food and Beverage, prioritizing Wellness, Personal Health, and Sustainability. They prefer contributing to funding rounds without leading them and have a global reach, investing in cities like Paris, Stockholm, and Zurich. Startups in health, wellness, biotech, and sustainable food, particularly those integrating tech for personal health improvement, would align well with Joyance Partners’ investment criteria.

With a good Beauty Funder Fit, beauty brands that pitch around health and wellness, sustainability with a backing of biotech will gain an interest

Layer 1